http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0466598-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5128cfc84a0fb189fceb3cd240c44493 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
filingDate | 1990-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52228facfd77db1a764691914b9dfb20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ccdd04c9ed59301eed7b9df988eae9c |
publicationDate | 1992-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H0466598-A |
titleOfInvention | Antigen peptide |
abstract | NEW MATERIAL:A peptide having 33000 molecular weight, existing in the blood serum of a patient of hepatic cancer and capable of specifically combining with NM17 mouse monoclonal antibody (antibody produced from hybridoma of Bikokenkinki no.10280). n USE: A cancer serum antigen useful for serodiagnosis of cancer and capable of immunotherapy of cancer by immune of the above-mentioned peptide purified. n PREPARATION: To a serum of a patient of hepatic cancer, an equal quantity of ConA cephalose is initially added and glycoprotein ATM1-17 is adsorbed thereon followed by elution using methy1-D-mannopyranoside. The resultant purified ConA is subjected to gel filtration chromatography and the eluted ATM1-17 contained in a fraction of 700000-1200000 molecular weight is then subjected to the ion-exchange chromatography method and eluted by the NaCl concentration gradient method. n COPYRIGHT: (C)1992,JPO&Japio |
priorityDate | 1990-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.